Avisa Pharma developing 10-minute tuberculosis breath test
Avisa Pharma is focusing primarily on tuberculosis detection, with aims to develop a rapid, point-of-care test that could determine if a patient has the disease within 10 minutes.
A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded
Seems these days as though breath analysis startups are all the rage – creating diagnostics that provide quick-turnover disease diagnosis. They’re primarily targeted to the public health set – allowing frontline health workers diagnose disease quickly can help expedite intervention time. New Mexico startup Avisa Pharma is developing a breath-based diagnostic that can rapidly detect […]
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.